Article: Synthesis of sulfonamide- and sulfonyl-phenylboronic acid-modified silica phases for boronate affinity chromatography at physiological pH

Two new types of boronate affinity solid phases were synthesized and characterized. The materials were prepared by silylation of porous silica gel with monochlorosilane derivatives containing synthetic sulfonyl- and sulfonamide-substituted phenylboronic acids. The new solid phases were evaluated for boronate affinity chromatography with aryl and alkyl cis-diol compounds and were found to be suitable for the retention of cis-diols under acidic conditions. Significant correlations between the retention factor (K) and the pH of the mobile phase demonstrate that the binding of cis-diols to the solid phases is best rationalized by chelation. Based on the lower pKa, caused by the electron-withdrawing effects of the sulfonyl and sulfonamide groups, these media display an enhanced affinity for cis-diols as compared with unsubstituted phenylboronic acid. Using isocratic elution, a mixture of various biologically relevant l-tyrosines, l-DOPA, and several catecholamines were resolved with a mobile phase composed of 0.05M phosphate buffer (pH 5.5). Mono-, di-, and triphosphates of adenosine were also separated at pH 6.0. Hence, the new boronate solid phase offers efficient affinity separation and purification of cis-diol-containing molecules under rather mild pH conditions.

Citing Articles

Impact of Hydrophobic, Hydrophilic, and Mucus-Binding Motifs on the Therapeutic Potential of Ceftazidime Analogs for Pulmonary Administration.

Apley K, Johnson S, Qian J, Munasinghe I, Klaus J, Patel S Antibiotics (Basel). 2025; 14(2).

PMID: 40001420 PMC: 11852049. DOI: 10.3390/antibiotics14020177.

Branched polyethyleneimine-assisted 3-carboxybenzoboroxole improved Wulff-type boronic acid functionalized magnetic nanoparticles for the specific capture of -diol-containing flavonoids under neutral conditions.

Li D, Liu Z, Song R, Yang W, Zhai S, Wang W RSC Adv. 2022; 9(65):38038-38046.

PMID: 35541768 PMC: 9075723. DOI: 10.1039/c9ra06250e.

Microneedle-based insulin transdermal delivery system: current status and translation challenges.

Zhao J, Xu G, Yao X, Zhou H, Lyu B, Pei S Drug Deliv Transl Res. 2021; 12(10):2403-2427.

PMID: 34671948 PMC: 8528479. DOI: 10.1007/s13346-021-01077-3.

Nanoparticles prepared from pterostilbene reduce blood glucose and improve diabetes complications.

Zhao X, Shi A, Ma Q, Yan X, Bian L, Zhang P J Nanobiotechnology. 2021; 19(1):191.

PMID: 34176494 PMC: 8237509. DOI: 10.1186/s12951-021-00928-y.

An Optimised Di-Boronate-ChemMatrix Affinity Chromatography to Trap Deoxyfructosylated Peptides as Biomarkers of Glycation.

Kijewska M, Nuti F, Wierzbicka M, Waliczek M, Ledwon P, Staskiewicz A Molecules. 2020; 25(3).

PMID: 32050527 PMC: 7037614. DOI: 10.3390/molecules25030755.

References

1.

Hage D . Clinical applications of high-performance affinity chromatography. Adv Chromatogr. 2003; 42:377-420. View

2.

Leeuwenburgh C, Hansen P, Shaish A, Holloszy J, Heinecke J . Markers of protein oxidation by hydroxyl radical and reactive nitrogen species in tissues of aging rats. Am J Physiol. 1998; 274(2):R453-61. DOI: 10.1152/ajpregu.1998.274.2.R453. View

3.

Shen L, Qiu S, Chen Y, Zhang F, van Breemen R, Nikolic D . Alkylation of 2'-deoxynucleosides and DNA by the Premarin metabolite 4-hydroxyequilenin semiquinone radical. Chem Res Toxicol. 1998; 11(2):94-101. DOI: 10.1021/tx970181r. View

4.

Bry L, Chen P, Sacks D . Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem. 2001; 47(2):153-63. View

5.

Singhal R, DeSilva S . Boronate affinity chromatography. Adv Chromatogr. 1992; 31:293-335. View

6.

Marumo K, Waite J . Optimization of hydroxylation of tyrosine and tyrosine-containing peptides by mushroom tyrosinase. Biochim Biophys Acta. 1986; 872(1-2):98-103. DOI: 10.1016/0167-4838(86)90152-4. View

7.

Burzio L, Waite J . Reactivity of peptidyl-tyrosine to hydroxylation and cross-linking. Protein Sci. 2001; 10(4):735-40. PMC: 2373961. DOI: 10.1110/ps.44201. View

8.

Leitner A, Lindner W . Current chemical tagging strategies for proteome analysis by mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2004; 813(1-2):1-26. DOI: 10.1016/j.jchromb.2004.09.057. View

9.

Schleicher E, Wieland O . Protein glycation: measurement and clinical relevance. J Clin Chem Clin Biochem. 1989; 27(9):577-87. View

10.

Li W, Nelson D, Jensen M, Hoerrner R, Cai D, Larsen R . An improved protocol for the preparation of 3-pyridyl- and some arylboronic acids. J Org Chem. 2002; 67(15):5394-7. DOI: 10.1021/jo025792p. View

11.

Miksik I, Deyl Z . Post-translational non-enzymatic modification of proteins. II. Separation of selected protein species after glycation and other carbonyl-mediated modifications. J Chromatogr B Biomed Sci Appl. 1997; 699(1-2):311-45. DOI: 10.1016/s0378-4347(97)00233-8. View

12.

Hoeg-Jensen T, Ridderberg S, Havelund S, Schaffer L, Balschmidt P, Jonassen I . Insulins with built-in glucose sensors for glucose responsive insulin release. J Pept Sci. 2005; 11(6):339-46. DOI: 10.1002/psc.624. View

Synthesis of Sulfonamide- and Sulfonyl-phenylboronic Acid-modified Silica Phases for Boronate Affinity Chromatography at Physiological PH